PT930077E - Composicoes de ciclodextrina compreendendo um derivado de avermectina ou de milbemicina - Google Patents
Composicoes de ciclodextrina compreendendo um derivado de avermectina ou de milbemicinaInfo
- Publication number
- PT930077E PT930077E PT98310562T PT98310562T PT930077E PT 930077 E PT930077 E PT 930077E PT 98310562 T PT98310562 T PT 98310562T PT 98310562 T PT98310562 T PT 98310562T PT 930077 E PT930077 E PT 930077E
- Authority
- PT
- Portugal
- Prior art keywords
- milbemycin
- avermectin
- cyclodextrin
- composing
- derivative
- Prior art date
Links
- 229920000858 Cyclodextrin Polymers 0.000 title abstract 2
- RRZXIRBKKLTSOM-XPNPUAGNSA-N avermectin B1a Chemical class C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 RRZXIRBKKLTSOM-XPNPUAGNSA-N 0.000 title abstract 2
- FXWHFKOXMBTCMP-WMEDONTMSA-N milbemycin Natural products COC1C2OCC3=C/C=C/C(C)CC(=CCC4CC(CC5(O4)OC(C)C(C)C(OC(=O)C(C)CC(C)C)C5O)OC(=O)C(C=C1C)C23O)C FXWHFKOXMBTCMP-WMEDONTMSA-N 0.000 title abstract 2
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical group O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title 1
- 239000005660 Abamectin Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nanotechnology (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Medical Informatics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biophysics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9801109.1A GB9801109D0 (en) | 1998-01-20 | 1998-01-20 | Cyclodextrin compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT930077E true PT930077E (pt) | 2003-07-31 |
Family
ID=10825529
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT98310562T PT930077E (pt) | 1998-01-20 | 1998-12-22 | Composicoes de ciclodextrina compreendendo um derivado de avermectina ou de milbemicina |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20020032161A1 (pt) |
| EP (1) | EP0930077B1 (pt) |
| JP (2) | JPH11255646A (pt) |
| AT (1) | ATE237359T1 (pt) |
| BR (1) | BR9900114A (pt) |
| CA (1) | CA2259699A1 (pt) |
| DE (1) | DE69813496T2 (pt) |
| DK (1) | DK0930077T3 (pt) |
| ES (1) | ES2194279T3 (pt) |
| GB (1) | GB9801109D0 (pt) |
| PT (1) | PT930077E (pt) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7091192B1 (en) * | 1998-07-01 | 2006-08-15 | California Institute Of Technology | Linear cyclodextrin copolymers |
| BRPI0200751B1 (pt) * | 2002-02-06 | 2018-10-23 | Univ Minas Gerais | complexos de inclusão de benzaldeído semicabazona em ciclodextrinas e seu método de preparação |
| EP2277551B1 (en) | 2002-09-06 | 2013-05-08 | Cerulean Pharma Inc. | Cyclodextrin-based polymers for delivering the therapeutic agents covalently bound thereto |
| WO2005014010A1 (en) * | 2003-07-24 | 2005-02-17 | Eli Lilly And Company | Pharmaceutical composition comprising gemcitabine and cyclodextrines |
| US20080176958A1 (en) | 2007-01-24 | 2008-07-24 | Insert Therapeutics, Inc. | Cyclodextrin-based polymers for therapeutics delivery |
| AU2008322995B2 (en) | 2007-11-15 | 2014-01-30 | Novartis Tiergesundheit Ag | Anthelmintic paste comprising praziquantel, a macrolide lactone, cyclodextrin and a thickener |
| EP2503888A4 (en) * | 2009-11-23 | 2015-07-29 | Cerulean Pharma Inc | POLYMERS ON CYCLODEXTRINBASIS FOR THERAPEUTIC ADMINISTRATION |
| US20140094432A1 (en) | 2012-10-02 | 2014-04-03 | Cerulean Pharma Inc. | Methods and systems for polymer precipitation and generation of particles |
| CN104208017A (zh) * | 2013-05-29 | 2014-12-17 | 镇江威特药业有限责任公司 | 一种伊维菌素溶液及其制备方法 |
| FR3042412A1 (fr) * | 2015-10-14 | 2017-04-21 | Biotopic Pharmaceuticals | Formulation pharmaceutique stabilisee et prete a l'emploi d'ivermectine dans le traitement des parasitoses humaines et animales |
| CA3043886A1 (en) * | 2016-11-16 | 2018-05-24 | Aivita Biomedical, Inc. | Use of cell membrane-bound signaling factors |
| EP3710060A4 (en) | 2017-11-16 | 2021-05-19 | Aivita Biomedical, Inc. | USE OF CELL MEMBRANE-RELATED SIGNALING FACTORS |
| CN108982883A (zh) * | 2018-07-16 | 2018-12-11 | 上海海洋大学 | 一种预测鲜切生菜货架期模型 |
| WO2022034226A1 (en) | 2020-08-14 | 2022-02-17 | Universidad De Navarra | Avermectin and milbemycin compositions for inhalation |
| US11253533B1 (en) * | 2020-11-10 | 2022-02-22 | Mountain Valley Md Inc | Water dissolvable macrocyclic lactone cyclodextrin complexes |
| US11077134B1 (en) * | 2020-11-10 | 2021-08-03 | Mountain Valley Md Inc | Water dissolvable macrocyclic lactone cyclodextrin complexes |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69619894T2 (de) * | 1995-06-30 | 2002-11-14 | American Cyanamid Co., Madison | Stabile Makrolide und Makrolide Imptstoff-Zusammensetzungen |
-
1998
- 1998-01-20 GB GBGB9801109.1A patent/GB9801109D0/en not_active Ceased
- 1998-12-22 DK DK98310562T patent/DK0930077T3/da active
- 1998-12-22 PT PT98310562T patent/PT930077E/pt unknown
- 1998-12-22 EP EP98310562A patent/EP0930077B1/en not_active Expired - Lifetime
- 1998-12-22 ES ES98310562T patent/ES2194279T3/es not_active Expired - Lifetime
- 1998-12-22 AT AT98310562T patent/ATE237359T1/de not_active IP Right Cessation
- 1998-12-22 DE DE69813496T patent/DE69813496T2/de not_active Expired - Fee Related
-
1999
- 1999-01-11 JP JP11003730A patent/JPH11255646A/ja active Pending
- 1999-01-18 CA CA002259699A patent/CA2259699A1/en not_active Abandoned
- 1999-01-19 BR BR9900114-4A patent/BR9900114A/pt not_active Application Discontinuation
-
2001
- 2001-09-26 US US09/963,237 patent/US20020032161A1/en not_active Abandoned
-
2005
- 2005-12-12 JP JP2005357820A patent/JP2006083186A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| ES2194279T3 (es) | 2003-11-16 |
| DE69813496T2 (de) | 2003-10-30 |
| EP0930077B1 (en) | 2003-04-16 |
| US20020032161A1 (en) | 2002-03-14 |
| ATE237359T1 (de) | 2003-05-15 |
| BR9900114A (pt) | 2000-05-02 |
| CA2259699A1 (en) | 1999-07-20 |
| EP0930077A1 (en) | 1999-07-21 |
| DE69813496D1 (de) | 2003-05-22 |
| DK0930077T3 (da) | 2003-08-04 |
| JP2006083186A (ja) | 2006-03-30 |
| GB9801109D0 (en) | 1998-03-18 |
| JPH11255646A (ja) | 1999-09-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9900114A (pt) | Composições de ciclodextrina. | |
| PT1318791E (pt) | Composicao farmaceutica semi-solida de isotretinoina | |
| PT1140993E (pt) | Derivados de glicopeptidos e composicoes farmaceuticas contendo os mesmos | |
| BR9810495A (pt) | Composição farmacêutica | |
| ES2181744T3 (es) | Hidratos de paclitaxel cristalinos. | |
| AR005640A1 (es) | Composiciones endoparasiticidas | |
| BRPI0111222B8 (pt) | derivados fosfonados de glicopeptídeo. | |
| NO985643L (no) | Antimikrobielle blandinger | |
| AR010375A1 (es) | Composiciones endo-ectoparasiticidas | |
| ATE309805T1 (de) | Verwendungsmethoden von makrozyklischen laktonen als mittel zur umkehrung der mehrfach- medikamentresistenz in krebs- und anderen zellen | |
| DK0960107T3 (da) | 6-Thiosubstituerede paclitaxeler | |
| PE20011289A1 (es) | Composiciones antihelminticas que comprenden lactonas macrociclicas y espirodioxepinoindoles | |
| BR9808581A (pt) | Estabilização de benzimidazóis sensìveis a ácido com combinações de aminoácido/ciclodextrina | |
| PT842934E (pt) | Agonistas de 5-ht1f | |
| BR0208274A (pt) | Composições antitumorais contendo derivados de taxano | |
| ES2129078T3 (es) | Preparacion farmaceutica que comprende un compuesto capaz de degradar los antibioticos beta-lactamicos y su utilizacion. | |
| BR0014775B1 (pt) | misturas antimicrobianas de 1,3-bis (hidroximetil) -5,5-dimetilidantoina e 1,2-benzisotiazolin-3-ona. | |
| EP1142573A4 (en) | Antibacterial medicinal compositions | |
| EP1834670A3 (en) | Anthelmintic compositions containing combinations of avermectins or milbemycins with bis-aryl compounds | |
| ES2164660T3 (es) | Derivados difluoro de avermectina. | |
| DE69936052D1 (de) | N1 modifizierte glycopeptide | |
| PT1142905E (pt) | Novo composto de depsipeptido | |
| ATE342734T1 (de) | Adenosin a1 antagonisten gegen männliche sterilität | |
| IT1273460B (it) | Formulazioni farmaceutiche ad azione antivirale per uso topico | |
| DZ2606A1 (fr) | Dérivés de carboxamidothiazoles leur préparation les compositions pharmaceutiques en contenant. |